2-[2-(2-cyclopropylethyl)-4-pyridinyl]-N-[3-(difluoromethyl)-1-[4-[4-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]butoxy]butyl]phenyl]pyrazol-4-yl]-1,3-oxazole-4-carboxamide
C45H48F2N8O6 — CID 159910356
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(2-cyclopropylethyl)-4-pyridinyl]-N-[3-(difluoromethyl)-1-[4-[4-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]butoxy]butyl]phenyl]pyrazol-4-yl]-1,3-oxazole-4-carboxamide
2-[2-(2-cyclopropylethyl)-4-pyridinyl]-N-[3-(difluoromethyl)-1-[4-[4-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]butoxy]butyl]phenyl]pyrazol-4-yl]-1,3-oxazole-4-carboxamide (PubChem CID 159910356) has the molecular formula C45H48F2N8O6 and a molecular weight of 834.92 g/mol. Its IUPAC name is 2-[2-(2-cyclopropylethyl)-4-pyridinyl]-N-[3-(difluoromethyl)-1-[4-[4-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]butoxy]butyl]phenyl]pyrazol-4-yl]-1,3-oxazole-4-carboxamide.
Molecular Properties
| Compound Name | 2-[2-(2-cyclopropylethyl)-4-pyridinyl]-N-[3-(difluoromethyl)-1-[4-[4-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]butoxy]butyl]phenyl]pyrazol-4-yl]-1,3-oxazole-4-carboxamide |
|---|---|
| PubChem CID | 159910356 |
| Molecular Formula | C45H48F2N8O6 |
| Molecular Weight | 834.92 g/mol |
| Exact Mass | 834.37 |
| IUPAC Name | 2-[2-(2-cyclopropylethyl)-4-pyridinyl]-N-[3-(difluoromethyl)-1-[4-[4-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]butoxy]butyl]phenyl]pyrazol-4-yl]-1,3-oxazole-4-carboxamide |
| SMILES | Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCCOCCCCc3ccc(-n4cc(NC(=O)c5coc(-c6ccnc(CCC7CC7)c6)n5)c(C(F)F)n4)cc3)cc21 |
| InChI | InChI=1S/C45H48F2N8O6/c1-53-38-24-30(13-17-36(38)55(45(53)59)37-18-19-39(56)51-43(37)58)7-3-5-23-60-22-4-2-6-28-11-15-33(16-12-28)54-26-34(40(52-54)41(46)47)49-42(57)35-27-61-44(50-35)31-20-21-48-32(25-31)14-10-29-8-9-29/h11-13,15-17,20-21,24-27,29,37,41H,2-10,14,18-19,22-23H2,1H3,(H,49,57)(H,51,56,58) |
| InChIKey | NXCLVUCOFVLWNU-UHFFFAOYSA-N |
| XLogP | 7.45 |
| TPSA | 168.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 834.92 |
| LogP ≤ 5 | 7.45 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159910356 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.